Cigarette smoking and thyroid eye disease: A systematic review

Eye

Volumn 21, Issue 9, 2007, Pages 1135-1145

  Thornton, J ^a   Kelly, S P ^b   Harrison, R A ^a,c   Edwards, R ^d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BOLTON NHS FOUNDATION TRUST   (United Kingdom)

^c Bolton Primary Care Trust   (United Kingdom)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CASE CONTROL STUDY; CAUSAL ATTRIBUTION; CIGARETTE SMOKING; COHORT ANALYSIS; DISEASE COURSE; DOSE RESPONSE; ENDOCRINE OPHTHALMOPATHY; HUMAN; INCIDENCE; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SMOKING CESSATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 34548534955     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702603     Document Type: Review

References (37)

1. Bartalena L, Pinchera, A, Marcocci C. Management of Graves' ophthalmopathy: Reality and perspectives. Endocr Rev 2000; 21 168-199.
2. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 2003; 24: 802-835.
3. Bartalena L, Marcocci C, Pinchera A. Graves 'ophthalmopathy: A preventable disease? Eur J Endocrinol 2002; 146: 457-461.
4. Cawood T, Moriarty P, O'Shea D. Recent developments in thyroid eye disease. BMJ 2004; 329: 385-390.
5. Hagg E, Asplund, K. Is endocrine ophthalmopathy related to smoking. BMJ 1987; 295: 634-635.
6. Krassas GE, Wiersinga W. Smoking and autoimmune thyroid disease: The plot thickens. Eur J Endocrinol 2006; 154: 777-780.
7. Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv Ophthalmol 1998; 42: 535-547.
8. Hegedus L, Brix TH, Vestergaard P. Relationship between cigarette smoking and Graves' ophthalmopathy. J Endocrinol Invest 2004; 27: 265-271.
9. Vestergaard P. Smoking and thyroid disorders - a meta-analysis. Eur J Endocrinol 2002; 146: 153-161.
10. Silman AJ, MacFarlane GJ. Studying associations between risk factors and disease. In: Silman AJ, MacFarlane GJ (eds). Epidemiological Studies: A Practical Guide. Cambridge University Press: Cambridge, 2002, pp 31-41.
11. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F et al. Evaluating non-randomised intervention studies. Health Technology Assessment (Winchester, England) 2003; 7: Iii-x, 1-173.
12. Critical Appraisal Skills Programme. Twelve questions to help you make sense of a cohort study. Update Software: Oxford, 1999.
13. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis (2006). http://www.ohrc.ca/ programs/clinical_epidemiology/oxford.htm.
14. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Commun Health 1998; 52: 377-384.
15. Friedenreich CM, Brant RF, Riboli E. Influence of methodologic factors in a pooled analysis of 13 case-control studies of colorectal cancer and dietary fiber. Epidemiology 1994; 5: 66-79.
16. Pfeilschifter J, Ziegler R. Smoking and endocrine ophthalmopathy: Impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol 1996; 45: 477-481.
17. Szucs-Farkas Z, Toth J, Kollar J, Galuska L, Burman KD, Boda J et al. Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: Effect of smoking. Thyroid 2005; 15: 146-151.
18. Marquez SD, Lum BL, McDougall IR, Katkuri S, Levin PS, MacManus M et al. Long-term results of irradiation for patients with progressive Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 2001; 51 766-774.
19. Tagami T, Tanaka K, Sugawa H, Nakamura H, Miyoshi Y, Mori T et al. High-dose intravenous steroid pulse therapy in thyroid-associated ophthalmopathy. Endocr J 1996; 43: 689-699.
20. Jensen BE, Bonnema SJ, Hegedus L. Glucocorticoids do not influence the effect of radioiodine therapy in Graves' disease. Eur J Endocrinol 2005; 153: 15-21.
21. Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell'Unto E, Bartolomei MP et al. Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Int Med 1998; 129: 632-635.
22. Shine B, Fells P, Edwards OM, Weetman AP. Association between Graves' ophthalmopathy and smoking. Lancet 1990; 335: 1261-1263.
23. Prummel MF, Wiersinga WM. Smoking and risk of Graves' disease. JAMA 1993; 269: 479-482.
24. Winsa B, Mandahl A, Karlsson FA. Graves' disease, endocrine ophthalmopathy and smoking. Acta Endocrinol 1993; 128: 156-160.
25. O'Hare JA, Geoghegan M. Cigarettes smoking as a promoter of Graves' disease. Eur J Int Med 1993; 4: 289-292.
26. Bartalena L, Martino E, Marcocci C, Bogazzi F, Panicucci M, Velluzzi F et al. More on smoking habits and Graves' ophthalmopathy. J Endocrinol Invest 1989; 12: 733-737.
27. Tallstedt L, Lundell G, Taube A. Graves' ophthalmopathy and tobacco smoking. Acta Endocrinol 1993; 129: 147-150.
28. Eckstein A, Quadbeck B, Mueller G, Rettenmeier AW, Hoermann R, Mann K et al. Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. Br J Ophthalmol 2003; 87: 773-776.
29. Nunery WR, Martin RT, Heinz GW, Gavin TJ. The association of cigarette smoking with clinical subtypes of ophthalmic Graves' disease. Ophthalmic Plast Reconstru Surg 1993; 9: 77-82.
30. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA et al. The treatment of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996; 121: 200-206.
31. Chen YL, Chang TC, Chen CJ. Influence of smoking on Graves' disease with or without ophthalmopathy and nontoxic nodular goiter in Taiwan. J Formos Med Assoc 1994; 93: 40-44.
32. Shiraishi S, Chuman H, Nao-i N, Sawada A, Ohzuno I. Influence of smoking on hyperthyroid ophthalmopathy. Jpn J Clin Ophthalmol 1997; 51 899-901.
33. Hill AB. The environment and disease: Association or causation? Proc R Soc Med 1965; 58: 295-300.
34. Susser M. What is a cause and how do we know one? A grammar for pragmatic epidemiology. Am J Epidemiol 1991; 133: 635-648.
35. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: A review of association. Eye 2005; 19: 935-944.
36. Kelly SP, Thornton J, Edwards R, Sahu A, Harrison R. Smoking and cataract: Review of causal association. J Cataract Refract Surg 2005; 31: 2395-2404.
37. Bidwell G, Sahu A, Edwards R, Harrison RA, Thornton J, Kelly SP. Perceptions of blindness related to smoking: A hospital-based cross-sectional study. Eye 2005; 19: 945-948.